Breast Cancer: 1,219 Real Stories

1,219 stories match breast cancer. 974 of them mention surgery.

Cancer Stories

A patient, who was diagnosed with Stage IV Invasive Ductal CarcinomaBreast Cancer

Breast Cancer Discovered After Widespread Bone Metastases

Patient Info: Anonymized, female, 40s | Stage IV

Biomarkers: ER 90–95%; PR 90–95%; HER2 IHC 0; Ki-67 5%; germline BRCA1/2 negative

Metastatic Site: bone, bone marrow

She was receiving ongoing letrozole and ribociclib for Stage IV hormone receptor-positive, HER2-negative breast cancer with diffuse bone involvement.

PubMed Central
OutcomeCare Ongoing
A patient, who was diagnosed with Stage IV Breast CancerBreast Cancer

Stage 2 breast cancer: lump discovered at 61, successful treatment

Patient Info: Anonymized, Female, 60s | Stage IV

Biomarkers: Breast neuroendocrine tumor was ER/PR strongly positive, HER2 1+

Metastatic Site: lung, mediastinal lymph nodes, bone (ribs, spine,…

After Stage IIA primary breast neuroendocrine tumor treated with lumpectomy, sentinel lymph-node biopsy, radiation, and short-duration anastrozole, the patient developed metastatic recurrence about 2 years later, declined additional therapy, entered hospice, and died 1 month later.

PubMed Central
OutcomeIn Memory
A patient, who was diagnosed with Stage I Invasive Ductal CarcinomaBreast Cancer

Male breast cancer history complicated by suspected bone disease and later IgG-kappa multiple myeloma

Patient Info: Anonymized, Male, 60s | Stage I

Biomarkers: Breast cancer was ER/PR-positive and HER2-negative by FISH. Later workup showed IgG-kappa multiple myeloma with IgH rearrangement.

The patient achieved very good partial response after KBD and completed autologous hematopoietic stem cell transplantation with engraftment, but later died of a novel coronavirus infection.

PubMed Central
OutcomeIn Memory
Erica, who was diagnosed with Stage I Invasive Lobular CarcinomaBreast Cancer

Stage I HR-Positive Invasive Lobular Carcinoma: Erica's Survivor Story

Patient Info: Erica, Female, 40s | Stage I

Biomarkers: ER-positive; PR-positive; HER2-negative

As of December 2025, Erica had Stage IA ER-positive/PR-positive/HER2-negative ILC removed with negative lymph nodes, completed 16 rounds of radiation, and was focused on survivorship and advocacy.

Lobular Breast Cancer Alliance
OutcomeSurvivorship / Completed Treatment
Chelsey, who was diagnosed with Stage IV Breast CancerBreast Cancer

Stage IV Triple-Negative Breast Cancer: Chelsey's Patient Story

Patient Info: Chelsey Pickthorn, Female | Stage IV

Biomarkers: Triple-negative breast cancer

As of December 2025, Chelsey was described as a patient advocate living with Stage IV triple-negative breast cancer, with the conversation focused on LGBTQ+ sexuality, relationships, disclosure, caregiving, body image, and inclusive cancer care.

Dear Cancer, I'm Beautiful (LBBC)
OutcomeLiving With Cancer
A patient, who was diagnosed with Stage IV Breast CancerBreast Cancer

Triple-negative breast cancer with occult metastasis in parathyroid and ectopic thyroid adenomas: complete remission after chemotherapy

Patient Info: Anonymized, Female, 60s | Stage IV

Biomarkers: Triple-negative breast cancer. Metastatic deposits were CK7 positive and negative for ER, HER2

Metastatic Site: parathyroid adenoma; ectopic thyroid adenoma /…

As of December 2025, she remained in complete remission 1 year after systemic chemotherapy for triple-negative breast cancer with occult metastatic deposits in parathyroid and ectopic thyroid adenomas.

PubMed Central
OutcomeCancer-Free / NED
A patient, who was diagnosed with Breast CancerBreast Cancer

Hormone receptor-positive breast cancer treated with pembrolizumab trial complicated by acquired lipodystrophy

Patient Info: Anonymized, Female, 40s

Biomarkers: HER2-negative breast cancer. Metabolic changes occurred during/after pembrolizumab.

As of December 2025, breast cancer treatment had included neoadjuvant chemotherapy/pembrolizumab, surgery, adjuvant pembrolizumab, and endocrine therapy; CT did not show recurrence during weight-loss evaluation, but she required ongoing metabolic care for pembrolizumab-associated acquired generalized lipodystrophy.

PubMed Central
OutcomeCare Ongoing
A patient, who was diagnosed with Stage IV Breast CancerBreast Cancer

Metastatic Breast Cancer Causing Bile Duct Obstruction and Liver Failure

Patient Info: Anonymized, female, Under 40 | Stage IV

Biomarkers: Metastatic biopsy ER-negative, PR-negative, HER2-negative

Metastatic Site: bone, liver, common bile duct

Her metastatic breast cancer progressed rapidly with diffuse liver involvement and bile-duct invasion, leading to liver failure and death 28 days after admission.

PubMed Central
OutcomeIn Memory
A patient, who was diagnosed with Breast AdenocarcinomaBreast Cancer

Breast cancer found during workup for progressive hearing loss and paraneoplastic cochleovestibulopathy

Patient Info: Anonymized, Female, 40s

Biomarkers: Breast cancer was ER ~100% and HER2 2+; CK/CK7/GATA3 supported breast origin. Neuronal autoantibodies were suspected but not identified.

As of December 2025, she remained on endocrine therapy, and serial chest CT at 1-year follow-up showed reduction in right axillary lymph-node size; hearing outcome after cochlear implantation was not assessable.

PubMed Central
OutcomeCare Ongoing
A patient, who was diagnosed with Invasive Ductal CarcinomaBreast Cancer

Breast cancer history with incidental adult cystic nephroma: no renal recurrence after nephrectomy

Patient Info: Anonymized, Female, 40s

Biomarkers: Breast cancer biomarkers not reported. Kidney cystic nephroma showed PAX8 in epithelium and PR in stroma, ER absent.

As of December 2025, the kidney lesion had been resected and proven to be adult cystic nephroma rather than breast cancer metastasis, with no clinical symptoms or radiologic recurrence at 1-year follow-up.

PubMed Central
OutcomeSurvivorship / Completed Treatment
A patient, who was diagnosed with Stage IV Invasive Ductal CarcinomaBreast Cancer

Young Woman With Breast Cancer and Four Inherited Cancer-Risk Variants

Patient Info: Anonymized, female, Under 40 | Stage IV

Biomarkers: ER 40%; PgR 60%; HER2 0; Ki-67 25%; germline pathogenic variants in ATM, PALB2, PMS2

Metastatic Site: brain

The breast cancer spread rapidly to the brain, and she died within a few months.

PubMed Central
OutcomeIn Memory
A patient, who was diagnosed with Stage IV Invasive Ductal CarcinomaBreast Cancer

Stage IV ER/PR-positive breast cancer with retinal vein and artery occlusion during endocrine-targeted therapy

Patient Info: Anonymized, Female, 50s | Stage IV

Biomarkers: ER 70%; PR 100%; HER2-negative; Ki-67 10%

Metastatic Site: bone (cranial vault, right first rib, sternum, D5, D6,…

As of November 2025, she continued care for Stage IV ER/PR-positive breast cancer with bone metastases while also managing severe left-eye retinal vascular occlusion and limited visual recovery.

PubMed Central
OutcomeCare Ongoing
A patient, who was diagnosed with Stage IV Breast CancerBreast Cancer

I Was Told I Was TOO YOUNG For Breast Cancer!

Patient Info: Anonymized, Female | Stage IV

Metastatic Site: mediastinum; lymph nodes between the lungs

As of November 2025, the patient was living with Stage IV metastatic breast cancer, described as lifelong and requiring ongoing treatment. She had also completed local treatment for a later breast lesion.

YouTube — The Patient Story
OutcomeLiving With Cancer
A patient, who was diagnosed with Stage IV Breast AdenocarcinomaBreast Cancer

Synchronous EGFR-mutated lung adenocarcinoma and metastatic breast cancer: surgery and adjuvant therapy

Patient Info: Anonymized, Female, 50s | Stage IV

Biomarkers: Two cancers: lung adenocarcinoma with EGFR exon 19 deletion; breast cancer ER-positive, PR-low, HER2 non-amplified.

Metastatic Site: lung

Follow-up CT on 26 December 2024 showed no recurrence, with disease-free survival estimated at 27 months to 1 April 2025 while on icotinib and letrozole maintenance.

PubMed Central
OutcomeCancer-Free / NED
Karen, who was diagnosed with Stage IV Invasive Lobular CarcinomaBreast Cancer

Stage IV Invasive Lobular Carcinoma: Karen's Patient Story

Patient Info: Karen, Female, 40s | Stage IV

Metastatic Site: bone marrow, lymph nodes

Karen was diagnosed in March 2020 with de novo Stage IV invasive lobular carcinoma involving lymph nodes and bone marrow, after mammograms and ultrasound were clear, and she died in 2024 from a rare metastasis.

Lobular Breast Cancer Alliance
OutcomeIn Memory